Tuesday, September 02, 2008

Klarman Family Foundation Grants Program in Eating Disorders Research

Klarman Family Foundation Grants Program in Eating Disorders Research
Program Officer: Gay Lockwood 617-279-2240 ext. 702

The Klarman Family Foundation Grants Program in Eating Disorders Research was established in 2008 to expand the number of outstanding scientists whose research explores the basic biology of anorexia nervosa, bulimia nervosa and/or binge eating disorder. The long term goal is to accelerate progress in developing effective treatments for these disorders. Examples of funding areas include but are not limited to molecular genetic analysis of relevant neural circuit assembly and function; animal models created by genetically altering neural circuits; testing of new chemical entities that might be used in animal models as exploratory treatments; and brain imaging approaches that identify neurochemical pathways in patients with these disorders. Clinical psychotherapeutic studies, medication trials and research in the medical complications of eating disorders are currently outside the scope of this Program.

For the 2009 cycle, two-year awards of $400,000 ($200,000 per year inclusive of 10% indirect costs) and one-year pilot studies of up to $150,000 (inclusive of 10% indirect costs) will be made to investigators with a faculty appointment at a nonprofit academic, medical or research institution in the United States, Canada or Israel. Eligibility is not limited to those investigators currently working in eating disorders research.

The next application deadline for the Initial Proposal Application is November 20, 2008 for awards beginning on June 1, 2009. Applications will be accepted through an online submission process.

Begin a new application

https://www.GrantRequest.com/SID_738?SA=SNA&FID=35024

Continue an existing application

https://www.GrantRequest.com/SID_738?SA=AM

RFA

Application Guidelines and Instructions

Terms of the Award

Frequently Asked Questions

Additional Reference Documents
Scientific Review Committee


No comments: